August 07, 2017
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
Guardion Health Sciences completes Series B funding
Guardion Health Sciences announced it has completed a Series B funding round with $3.1 million raised, according to a company press release.
The money is to be used in accelerating expansion of the company’s operations, implementing its sales and marketing strategy, and completing development of products in its pipeline, the release said.
Guardion Health Sciences formulates and distributes medical foods, specifically those that address depleted macular protective pigment.